PALLA PHARMA NORWAY HOLDING AS

3770 KRAGERØ

Finances

Return on Equity

−308,11 %

Current Ratio

1,58

Debt-to-Equity Ratio

1,02

Key figures (NOK)	2022	2021	2020	2019
Revenue	83 926 000	97 211 000	0	0
Net Income	−75 572 000	−112 552 000	−92 003 000	−6 367 000
Total Assets	93 158 000	98 725 000	95 689 000	178 025 000
Total Equity	24 528 000	−296 847 000	−66 899 000	25 104 000

Income (NOK)	2022	2021	2020	2019
Revenue	83 926 000	97 211 000	0	0
Expenditure	159 390 000	201 174 000	0	0
Operating Profit	−75 463 000	−103 962 000	0	0
Financial Income	1 101 000	2 533 000	4 474 000	4 474 000
Financial Costs	1 209 000	11 123 000	96 477 000	10 539 000
Financial Balance	−108 000	−8 590 000	−92 003 000	−6 065 000
Earnings Before Tax	−75 572 000	−112 552 000	−92 003 000	−6 065 000
Tax	0	0	0	302 000
Net Income	−75 572 000	−112 552 000	−92 003 000	−6 367 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	24 271 000	21 823 000	82 000 000	168 811 000
Total Current Assets	68 886 000	76 902 000	13 689 000	9 214 000
Total Assets	93 158 000	98 725 000	95 689 000	178 025 000
Total Retained Equity	0	−330 713 000	−100 765 000	−8 762 000
Total Equity	24 528 000	−296 847 000	−66 899 000	25 104 000
Total Long-Term Debt	25 000 000	106 440 000	106 000 000	106 000 000
Total Current Debt	43 630 000	289 132 000	56 587 000	46 921 000
Total Equity and Debt	93 158 000	98 725 000	95 689 000	178 025 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	83 238 000	97 111 000	0	0
Other Income	689 000	100 000	0	0
Revenue	83 926 000	97 211 000	0	0
Cost of Goods Sold	55 296 000	93 819 000	0	0
Salary Costs	59 044 000	60 225 000	0	0
Depreciation	4 026 000	3 641 000	0	0
Impairment	0	0	0	0
Expenditure	159 390 000	201 174 000	0	0
Operating Profit	−75 463 000	−103 962 000	0	0
Financial Income	1 101 000	2 533 000	4 474 000	4 474 000
Financial Costs	1 209 000	11 123 000	96 477 000	10 539 000
Financial Balance	−108 000	−8 590 000	−92 003 000	−6 065 000
Dividends	0	0	0	0
Net Income	−75 572 000	−112 552 000	−92 003 000	−6 367 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	4 047 000	0	0	0
Total Intangible Assets	4 103 000	182 000	0	0
Real Eastate	1 810 000	1 958 000	0	0
Machinery and Plant Facilities	16 957 000	18 264 000	0	0
Fixtures	1 401 000	1 419 000	0	0
Total Tangible Assets	20 168 000	21 641 000	0	0
Total Fiancial Fixed Assets	0	0	82 000 000	168 811 000
Total Fixed Assets	24 271 000	21 823 000	82 000 000	168 811 000
Stock	47 363 000	47 505 000	0	0
Total Investments	0	0	0	0
Cash, Bank	3 439 000	3 566 000	0	0
Total Current Assets	68 886 000	76 902 000	13 689 000	9 214 000
Total Assets	93 158 000	98 725 000	95 689 000	178 025 000
Total Equity	24 528 000	−296 847 000	−66 899 000	25 104 000
Short-Term Group Debt	0	263 223 000	56 587 000	46 921 000
Total Long-Term Debt	25 000 000	106 440 000	106 000 000	106 000 000
Creditors	12 752 000	16 413 000	0	0
Unpaid Taxes	2 195 000	2 072 000	0	0
Dividends	0	0	0	0
Other Current Debt	10 141 000	7 423 000	0	0
Total Current Debt	43 630 000	289 132 000	56 587 000	46 921 000
Total Equity and Debt	93 158 000	98 725 000	95 689 000	178 025 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−308,11 %	37,92 %	137,53 %	−25,36 %
Debt-to-Equity Ratio	1,02	−0,36	−1,58	4,22
Operating Profit Margin	−89,92 %	−106,94 %	-	-
Current Ratio	1,58	0,27	0,24	0,2
Quick Ratio	−18,45	0,32	0,24	0,2
Equity Ratio	0,26	−3,01	−0,7	0,14
Gross Profit Margin	34,11 %	3,49 %	-	-